Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Adrenal & Rare Endocrine Cancers

Karel Pacak

卡雷尔·帕恰克

MD, PhD, DSc

🏢National Institutes of Health / NICHD(美国国立卫生研究院/国家儿童健康与人类发展研究所)🌐USA

Senior Investigator and Chief, Section on Medical Neuroendocrinology资深研究员兼医学神经内分泌学科主任

65
h-index
3
Key Papers
2
Awards
3
Key Contributions

👥Biography 个人简介

Karel Pacak at NIH/NICHD is a global authority on pheochromocytoma and paraganglioma (PPGL), leading landmark research on SDH-related hereditary syndromes, biochemical diagnosis, and novel imaging modalities. His work defined the genotype-phenotype landscape of PPGL and shaped international diagnostic criteria.

Share:

🧪Research Fields 研究领域

Pheochromocytoma嗜铬细胞瘤
Paraganglioma副神经节瘤
SDH MutationsSDH基因突变

🎓Key Contributions 主要贡献

Genotype-Phenotype Correlations in PPGL

Established landmark correlations between germline mutations (SDHB, SDHD, VHL, RET, NF1) and tumor phenotype, biochemical secretion patterns, and malignant potential.

Biochemical Diagnosis Optimization

Championed plasma metanephrine measurement as the most sensitive and specific biochemical test for pheochromocytoma, now a global diagnostic standard.

Functional Imaging Advances

Led NIH studies validating 18F-DOPA and 18F-FDA PET/CT for PPGL localization, improving tumor detection particularly in SDH-mutated hereditary cases.

Representative Works 代表性著作

[1]

Pheochromocytoma: Recommendations for Clinical Practice from the First International Symposium

Nature Clinical Practice Endocrinology & Metabolism (2007)

Consensus recommendations establishing diagnostic biochemical algorithms and imaging strategies for pheochromocytoma management.

[2]

Succinate Dehydrogenase-Related Pheochromocytoma and Paraganglioma

Endocrine Reviews (2011)

Comprehensive review of SDH mutation spectrum, risk stratification, surveillance protocols, and treatment for hereditary PPGL syndromes.

[3]

Biochemical Diagnosis of Pheochromocytoma: Which Test Is Best?

JAMA (2002)

Landmark study demonstrating superiority of plasma free metanephrines over urinary catecholamines for pheochromocytoma diagnosis.

🏆Awards & Recognition 奖项与荣誉

🏆Endocrine Society Distinguished Investigator Award
🏆American Physiological Society Carl Ludwig Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 卡雷尔·帕恰克 的研究动态

Follow Karel Pacak's research updates

留下邮箱,当我们发布与 Karel Pacak(National Institutes of Health / NICHD)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment